Floatz logo

Therapeutic Asset Ratings

205 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Evomela
Mantle Cell Lymphoma
Ruijin HospitalP3B (60)
Azacitidine
Myeloid Sarcoma
Ruijin HospitalP2B (60)
Zanubrutinib
Large B-Cell Lymphoma (LBCL)
Ruijin HospitalP2B (60)
BMS-986345
Chronic Lymphocytic Leukemia
Ruijin HospitalP3B (58)
cc-5013
Large B-cell Lymphoma
Ruijin HospitalP3B (58)
5-azacytidine
PTCL
Ruijin HospitalP2B (58)
Apg-2575
DLBCL - Diffuse Large B Cell Lymphoma
Ruijin HospitalP2B (58)
Capecitabine
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Ruijin HospitalP2B (58)
Jwcar029
DLBCL - Diffuse Large B Cell Lymphoma
Ruijin HospitalP2B (58)
Obutinib
Diffuse Large B Cell Lymphoma (DLBCL)
Ruijin HospitalP2B (58)
Polatuzumab Vedotin
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Ruijin HospitalP2B (58)
Selinexor
Central Nervous System Lymphoma
Ruijin HospitalP2B (58)
Tislelizumab
Peripheral T Cell Lymphoma
Ruijin HospitalP2B (58)
Toripalimab
Pancreatic Neoplasm
Ruijin HospitalP2B (58)
Zanubrutinib
CNS Lymphoma
Ruijin HospitalP2B (58)
Zeprumetostat
PTCL
Ruijin HospitalP2B (58)
Tegodor
Hepatic Metastasis of Pancreatic Cancer
Ruijin HospitalP2B (57)
Tegodor
Pancreatic Neoplasms
Ruijin HospitalP2B (57)
BMS-986345
Follicular Lymphoma
Ruijin HospitalP3B (56)
Duvelisib
Follicular Lymphoma
Ruijin HospitalP3B (56)
ag-120
Myelodysplastic Syndromes
Ruijin HospitalP2B (56)
Zanubrutinib
Large B-cell Lymphoma
Ruijin HospitalP2CCC (55)
Avastinib
MDS
Ruijin HospitalP2/3CCC (55)
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Parkinson Disease
Ruijin HospitalP3CCC (54)
BMS-986345
Marginal Zone Lymphoma
Ruijin HospitalP3CCC (54)
Showing 51 to 75 of 205 assets
PreviousPage 3 of 9Next